{"altmetric_id":15143995,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"total":{"posts_count":2},"blogs":{"unique_users_count":1,"unique_users":[57867],"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["Mucosal_Immunol"],"posts_count":1}},"citation":{"authors":["Ranc\u00e9s Blanco","Shifalika Tangutoori"],"doi":"10.4172\/2155-9929.1000i101","first_seen_on":"2016-12-30T11:51:26+00:00","issns":["ISSN-2155-9929","21559929"],"issue":"06","journal":"Journal of Molecular Biomarkers & Diagnosis","last_mentioned_on":1483098672,"links":["https:\/\/www.omicsonline.org\/open-access\/aberrant-expression-of-nglycolyl-gm3-ganglioside-in-hepatocellular-carcinoma-2155-9929-1000i101.php?aid=82825","http:\/\/www.omicsonline.org\/open-access\/the-cytoskeleton-as-biomarker-angiosarcoma-cytoskeleton-2155-9929.1000I101.php?aid=31954"],"pdf_url":"http:\/\/www.omicsonline.org\/open-access\/aberrant-expression-of-nglycolyl-gm3-ganglioside-in-hepatocellular-carcinoma-2155-9929-1000i101.pdf","pubdate":"2016-08-23T00:00:00+00:00","publisher":"OMICS International","title":"Aberrant Expression of N-Glycolyl GM3 Ganglioside in Hepatocellular Carcinoma","type":"article","volume":"07"},"altmetric_score":{"score":8,"score_history":{"1y":1,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":8},"context_for_score":null},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/Mucosal_Immunol\/statuses\/814801003434283008","license":"gnip","citation_ids":[15143995],"posted_on":"2016-12-30T11:51:12+00:00","author":{"name":"Mucosal Immunology","image":"https:\/\/pbs.twimg.com\/profile_images\/889808991055888386\/b5_6aIiu_normal.jpg","id_on_source":"Mucosal_Immunol","tweeter_id":"802521184638095361","geo":{"lt":null,"ln":null},"followers":8},"tweet_id":"814801003434283008"}],"blogs":[{"title":"Diagnostics Industry and Drug Development in the Genomics Era: Mid 80s to Present","url":"http:\/\/pharmaceuticalintelligence.com\/2014\/11\/21\/diagnostics-industry-and-drug-development-in-the-genomics-era-mid-80s-to-present\/","citation_ids":[3826023,15143995,21569923,21569926,4856496,21569930,21569934,21569936,21569937,21569938,2724052,1272368,2740152,2740151],"posted_on":"2014-11-22T02:01:00+00:00","summary":"Diagnostics Industry and Drug Development in the Genomics Era: Mid 80s to Present Author and Curator: Larry H Bernstein, MD, FCAP This article is a Chronological continuation to my article Milestones in the Evolution of Diagnostics in the US HealthCare Sys","author":{"name":"Pharmaceutical Intelligence","url":"http:\/\/pharmaceuticalintelligence.com\/","description":"A blog specializing in Pharmaceutical Intelligence and Analytics"}}]}}